287 related articles for article (PubMed ID: 12423664)
1. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B
Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664
[TBL] [Abstract][Full Text] [Related]
2. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
Bardin L; Tarayre JP; Malfetes N; Koek W; Colpaert FC
Pharmacology; 2003 Apr; 67(4):182-94. PubMed ID: 12595749
[TBL] [Abstract][Full Text] [Related]
3. The novel analgesic and high-efficacy 5-HT1A receptor agonist, F 13640 induces c-Fos protein expression in spinal cord dorsal horn neurons.
Buritova J; Tarayre JP; Besson JM; Colpaert F
Brain Res; 2003 Jun; 974(1-2):212-21. PubMed ID: 12742639
[TBL] [Abstract][Full Text] [Related]
4. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
Bruins Slot LA; Koek W; Tarayre JP; Colpaert FC
Eur J Pharmacol; 2003 Apr; 466(3):271-9. PubMed ID: 12694810
[TBL] [Abstract][Full Text] [Related]
5. Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
Bardin L; Colpaert FC
Eur J Pain; 2004 Jun; 8(3):253-61. PubMed ID: 15109976
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain.
Deseure K; Koek W; Colpaert FC; Adriaensen H
Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569
[TBL] [Abstract][Full Text] [Related]
7. The median effective dose of ketamine and gabapentin in opioid-induced hyperalgesia in rats: an isobolographic analysis of their interaction.
Van Elstraete AC; Sitbon P; Benhamou D; Mazoit JX
Anesth Analg; 2011 Sep; 113(3):634-40. PubMed ID: 21642613
[TBL] [Abstract][Full Text] [Related]
8. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
Kiss I; Degryse AD; Bardin L; Gomez de Segura IA; Colpaert FC
Eur J Pharmacol; 2005 Oct; 523(1-3):29-39. PubMed ID: 16226246
[TBL] [Abstract][Full Text] [Related]
9. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
Deseure K; Bréand S; Colpaert FC
Eur J Pharmacol; 2007 Jul; 568(1-3):134-41. PubMed ID: 17512927
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of a rat model of incisional pain.
Whiteside GT; Harrison J; Boulet J; Mark L; Pearson M; Gottshall S; Walker K
Br J Pharmacol; 2004 Jan; 141(1):85-91. PubMed ID: 14597606
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal gabapentin enhances the analgesic effects of subtherapeutic dose morphine in a rat experimental pancreatitis model.
Smiley MM; Lu Y; Vera-Portocarrero LP; Zidan A; Westlund KN
Anesthesiology; 2004 Sep; 101(3):759-65. PubMed ID: 15329602
[TBL] [Abstract][Full Text] [Related]
12. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
Colpaert FC
Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin prevents delayed and long-lasting hyperalgesia induced by fentanyl in rats.
Van Elstraete AC; Sitbon P; Mazoit JX; Benhamou D
Anesthesiology; 2008 Mar; 108(3):484-94. PubMed ID: 18292686
[TBL] [Abstract][Full Text] [Related]
14. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery.
Hayashida K; DeGoes S; Curry R; Eisenach JC
Anesthesiology; 2007 Mar; 106(3):557-62. PubMed ID: 17325515
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
16. The effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests.
Hansen C; Gilron I; Hong M
Anesth Analg; 2004 Oct; 99(4):1180-1184. PubMed ID: 15385372
[TBL] [Abstract][Full Text] [Related]
17. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
Bardin L; Assié MB; Pélissou M; Royer-Urios I; Newman-Tancredi A; Ribet JP; Sautel F; Koek W; Colpaert FC
J Pharmacol Exp Ther; 2005 Mar; 312(3):1034-42. PubMed ID: 15528450
[TBL] [Abstract][Full Text] [Related]
18. Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain.
LaBuda CJ; Fuchs PN
Neurosci Lett; 2000 Aug; 290(2):137-40. PubMed ID: 10936696
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.
Field MJ; Oles RJ; Lewis AS; McCleary S; Hughes J; Singh L
Br J Pharmacol; 1997 Aug; 121(8):1513-22. PubMed ID: 9283683
[TBL] [Abstract][Full Text] [Related]
20. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
